» Articles » PMID: 24412092

Osteoblast Recruitment Routes in Human Cancellous Bone Remodeling

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2014 Jan 14
PMID 24412092
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

It is commonly proposed that bone forming osteoblasts recruited during bone remodeling originate from bone marrow perivascular cells, bone remodeling compartment canopy cells, or bone lining cells. However, an assessment of osteoblast recruitment during adult human cancellous bone remodeling is lacking. We addressed this question by quantifying cell densities, cell proliferation, osteoblast differentiation markers, and capillaries in human iliac crest biopsy specimens. We found that recruitment occurs on both reversal and bone-forming surfaces, as shown by the cell density and osterix levels on these respective surfaces, and that bone formation occurs only above a given cell density. Canopies appeared an important source of osteoprogenitors, because (i) canopy cells proved to be more proliferative and less differentiated than bone surface cells, as shown by the inverse levels of Ki-67 and procollagen-3 N-terminal peptide versus osterix, and (ii) canopy cell densities, found to decline with age, and canopy-capillary contacts above eroded surfaces correlated positively with osteoblast density on bone-forming surfaces. Furthermore, we showed that bone remodeling compartment canopies arise from a mesenchymal envelope surrounding the red bone marrow, which is lifted and hypertrophied on initiation of bone resorption. This study, together with earlier reports, led to a model in which canopies and nearby capillaries are critical for reaching the osteoblast density required for bone formation.

Citing Articles

Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect.

El-Masri B, Andreasen C, Laursen K, Kofod V, Dahl X, Nielsen M Bone Res. 2024; 12(1):62.

PMID: 39424806 PMC: 11489716. DOI: 10.1038/s41413-024-00362-4.


Osteogenic Differentiation Potential of iMSCs on GelMA-BG-MWCNT Nanocomposite Hydrogels.

Arambula-Maldonado R, Mequanint K Biomimetics (Basel). 2024; 9(6).

PMID: 38921218 PMC: 11201442. DOI: 10.3390/biomimetics9060338.


Phlpp1 Expression in Osteoblasts Plays a Modest Role in Bone Homeostasis.

Karkache I, Molstad D, Vu E, Jensen E, Bradley E JBMR Plus. 2023; 7(12):e10806.

PMID: 38130760 PMC: 10731110. DOI: 10.1002/jbm4.10806.


Transitory Activation and Improved Transition from Erosion to Formation within Intracortical Bone Remodeling in Hypoparathyroid Patients Treated with rhPTH(1-84).

van Dijk Christiansen P, Sikjaer T, Andreasen C, Thomsen J, Bruel A, Hauge E JBMR Plus. 2023; 7(12):e10829.

PMID: 38130746 PMC: 10731115. DOI: 10.1002/jbm4.10829.


Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease.

Johansen M, Levring M, Stokbro K, Diaz-delCastillo M, Khan A, Wickstroem L Cancers (Basel). 2023; 15(23).

PMID: 38067289 PMC: 10705210. DOI: 10.3390/cancers15235585.